An Evidence-based Approach to Controlling Drug Costs
Summary
Optimizing the dosing of many expensive drugs can drastically reduce both costs and toxicities. The Federal Government, state governments, employers, and individual patients could collectively save tens of billions of dollars each year by simply optimizing the dosing of the most expensive prescription drugs on the market, particularly in oncology. Optimized dosing can also improve health outcomes. The next administration should, therefore, launch an effort to control the cost of prescription drugs through an evidence-based approach to optimizing drug dosing and improving outcomes. The requisite trials pay for themselves in immediate cost savings.
99% of the natural gas sampled near the point of extraction across the country contains hazardous air pollutants harmful to health.
The Federation of American Scientists supports the Wildfire Emissions Prevention Act of 2026 (WEPA). The Act would amend Section 319(b) of the Clean Air Act so that it addresses prescribed burns as a standalone activity. If passed, this bill would support wildfire resilience by reducing administrative barriers to getting needed prescribed burns on the ground. […]
The NCARS Act would amend the National Security Act of 1947 to establish a durable, coordinated federal approach to national resilience.
Nearly 150 organizations and government officials have endorsed the call to action and solutions for extreme heat, now public at HeatAgenda.US Washington, D.C. – July 7, 2026 – As millions of Americans continue to struggle to stay cool following one of the hottest Independence Day holidays on record, the Federation of American Scientists (FAS), one […]